Agenus, Inc. (AGEN)
7.67
-0.42
(-5.19%)
USD |
NASDAQ |
Aug 24, 16:00
7.67
0.00 (0.00%)
After-Hours: 20:00
Agenus Total Liabilities (Quarterly) : 378.54M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 378.54M |
| March 31, 2026 | 414.44M |
| December 31, 2025 | 504.66M |
| September 30, 2025 | 514.76M |
| June 30, 2025 | 521.53M |
| March 31, 2025 | 522.60M |
| December 31, 2024 | 532.70M |
| September 30, 2024 | 510.29M |
| June 30, 2024 | 513.25M |
| March 31, 2024 | 446.88M |
| December 31, 2023 | 462.30M |
| September 30, 2023 | 450.76M |
| June 30, 2023 | 460.35M |
| March 31, 2023 | 465.96M |
| December 31, 2022 | 468.46M |
| September 30, 2022 | 440.86M |
| June 30, 2022 | 442.54M |
| March 31, 2022 | 413.66M |
| December 31, 2021 | 418.05M |
| September 30, 2021 | 402.09M |
| June 30, 2021 | 429.78M |
| March 31, 2021 | 410.27M |
| December 31, 2020 | 399.10M |
| September 30, 2020 | 383.89M |
| June 30, 2020 | 384.83M |
| Date | Value |
|---|---|
| March 31, 2020 | 355.64M |
| December 31, 2019 | 359.76M |
| September 30, 2019 | 352.76M |
| June 30, 2019 | 341.40M |
| March 31, 2019 | 331.82M |
| December 31, 2018 | 271.07M |
| September 30, 2018 | 261.87M |
| June 30, 2018 | 245.02M |
| March 31, 2018 | 244.05M |
| December 31, 2017 | 214.22M |
| September 30, 2017 | 200.86M |
| June 30, 2017 | 193.97M |
| March 31, 2017 | 194.36M |
| December 31, 2016 | 196.11M |
| September 30, 2016 | 195.88M |
| June 30, 2016 | 179.58M |
| March 31, 2016 | 176.69M |
| December 31, 2015 | 171.50M |
| September 30, 2015 | 165.63M |
| June 30, 2015 | 92.92M |
| March 31, 2015 | 71.07M |
| December 31, 2014 | 51.51M |
| September 30, 2014 | 38.76M |
| June 30, 2014 | 42.56M |
| March 31, 2014 | 45.02M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 179.49M |
| Novavax, Inc. | 1.146B |
| Fate Therapeutics, Inc. | 106.66M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 172.69M |
| Shareholders Equity (Quarterly) | -199.08M |
| Debt to Equity Ratio | -1.458 |
| Current Ratio | 0.34 |
| Net Debt Paydown Yield | 19.44% |